Table IV.
vacA, cagA and iceA status of H. pylori from 197 patients.
| Clinical status
|
||||
|---|---|---|---|---|
| Genotype status | GUa n=86 (%) | GSb n=58 (%) | GCc n=53 (%) | Total n=197 (%) |
| vacA | ||||
| s1am2 | 4 (4.6) | 2 (3.4) | 0 (0.0) | 6 (3.0) |
| s1bm2 | 0 (0.0) | 0 (0.0) | 5 (9.4) | 5 (2.5) |
| s1cm1 | 16 (18.6) | 4 (6.9) | 0 (0.0) | 20 (10.2) |
| s1cm2 | 51 (59.4) | 43 (74.2) | 45 (84.9)d | 139 (70.6) |
| s1cm1m2 | 15 (17.4) | 9 (15.5) | 3 (5.7) | 27 (13.7) |
| cagA | ||||
| cagA+ | 78 (90.7) | 53 (91.4) | 45 (84.9) | 176 (89.3) |
| cagA− | 8 (9.3) | 5 (8.6) | 8 (15.1) | 21 (10.7) |
| iceA | ||||
| iceA1 | 63 (73.3) | 34 (58.6) | 41 (77.4)d | 138 (70.0) |
| iceA2 | 14 (16.3) | 21 (36.2) | 11 (20.8) | 46 (23.4) |
| iceA1/iceA2 | 9 (10.4) | 3 (5.2) | 1 (1.9) | 13 (6.6) |
a
Gastric ulcer;
b
gastritis;
c
gastric cancer.
d
P<0.05.